SavedAdd your journal

Journals / Etlik Veteriner Mikrobiyoloji Dergisi / 2022 / Cilt: 33 - Sayı: 1

DIVA (Differentiating Infected from Vaccinated Animals) Vaccines and Strategies

DIVA (Differentiating Infected from Vaccinated Animals) Aşı ve Stratejileri

Asena Esra ERDEM
Barış SAREYYÜPOĞLU
Pages
102–109
Publication Date
2022-06-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In veterinary medicine, vaccination is one of the most effective techniques for control and prevention of diseases.
📊
Key Findings & Data:When other methods fail in control of animal diseases, different vaccines and strategies are developed.
💡
Conclusion & Impact:In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:aşı · DIVA · marker aşıları

Abstract

In veterinary medicine, vaccination is one of the most effective techniques for control and prevention of diseases. When other methods fail in control of animal diseases, different vaccines and strategies are developed. DIVA (Differentiating Infected from Vaccinated Animals) vaccines lacking one or more antigenic epitope(s)/ protein(s) in the prevailing field strain and the accompanying diagnostic tests are effective in eradication and control of diseases. While currently used vaccines can not distinguish between vaccinated and infected animals, DIVA vaccines can be very useful for the purpose. Serological tests, such as ELISA (Enzyme-Linked ImmunoSorbent Assay), used together with DIVA vaccines, can be used to determine which animals are infected and which are vaccinated. DIVA vaccines and strategies for some animal diseases have been developed and continue to be developed. In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.

Özet

Veteriner hekimlik alanında aşılama, hastalıkların önlenmesi ve kontrolünde en etkili yöntemlerden birisidir. Hayvan hastalıklarının kontrolünde mevcut yöntemler başarısız olduğunda, farklı aşı ve stratejiler geliştirilmektedir. Saha suşunda yer alan bir veya daha fazla antijenik epitop veya proteinden yoksun olan DIVA (Differentiating Infected from Vaccinated Animals) aşıları ve beraberinde kullanılan tanı testleri, hastalıkların eradikasyonu ve kontrolünde oldukça etkilidir. Mevcut aşılar, aşılı ve enfekte hayvanların ayrımını sağlayamazken, DIVA aşıları bu alanda önemli yararlar sağlar. Bunun yanında ELISA (Enzyme-Linked ImmunoSorbent Assay) gibi DIVA aşılarıyla birlikte kullanılan serolojik testler, hangi hayvanların enfekte ve hangilerinin aşılı olduğunun ayrımı için kullanılabilir. Bazı hayvan hastalıklarına yönelik DIVA aşı ve stratejileri geliştirilmiş ve diğerleri için de geliştirilmeye devam edilmektedir. Bu derlemede, DIVA aşı ve stratejilerinin genel özelliklerini, önemini, üretimini, avantajlarını ve bunların çeşitli hayvan hastalıklarında kullanımını açıklamak amaçlanmıştır.

🔖

Cite This Article

ERDEM, A. E., SAREYYÜPOĞLU, B. (2022). DIVA (Differentiating Infected from Vaccinated Animals) Vaccines and Strategies. Etlik Veteriner Mikrobiyoloji Dergisi, Cilt: 33 - Sayı: 1, 102–109. https://ajindex.com/articles/664986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Akan M, Öncel T, Sareyyüpoğlu B, Hazıroğlu R, Tel OY, Cantekin Z. (2006) Vaccination studies of lambs against experimental Manheimia (Pasteurella) haemolytica infection. Small Rum Res. 65, 44-50.
  2. Alhaj M. (2016) Safety and efficacy profile of commercial veterinary vaccines against Rift Valley fever: a review study. J Immunol Res. 2016, 1-7.
  3. Arda M, Sareyyüpoğlu B. (2004)
  4. Aşılar, Hazırlama Teknikleri, Avantaj ve Dezavantajları. First edition. Ankara: İnkansa Publication, p.26-29.
  5. Arda M. (2011) Temel Mikrobiyoloji. Fourth edition. Ankara: Medisan yayınevi, p.459-468.
  6. Baron MD, Iqbal M, Nair V. (2018) Recent advances in viral vectors in veterinary vaccinology. Curr Opin Virol. 29, 1-7.
  7. Bhatt M, Mohapatra JK, Pandey LK, Mohanty NN, Das B, Prusty BR, Pattnaik B. (2018) Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus. Virus Res. 243, 36-43.
  8. Blome S, Moß C, Reimann I, Könıg P, Beer M. (2017a) Classical swine fever vaccines-State-of-the-art. Vet Microbiol. 206, 10-20.
  9. Blome S, Wernike K, Reimann I, König P, Moß C, Beer M. (2017b) A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties. Vet Res. 48, 1-10.
  10. Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF. (2003) Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 32, 47-55.
  11. Chaudhuri P, Saminathan M, Ali SA, Kaur G, Singh SV, Lalsiamthara J, Goswami TK, Singh AK, Singh SK, Malik, Singh RK. (2021) Immunization with Brucella abortus S19Δper Conferred Protection in Water Buffaloes against Virulent Challenge with B. abortus Strain S544. Vaccines. 9(12), 1423. Conlan AJ, Pollock EB, McKinley TJ, Mitchell AP, Jones GJ, Vordermeier M, Wood JL. (2015) Potential benefits of cattle vaccination as a supplementary control for bovine tuberculosis. PLoS Comput Biol. 11, e1004038. Day MJ, Schultz RD. (2014) Veterinary Immunology – Principles and Practice. Second edition. Florida: CRC Press, p. 235-240,
  12. Dhama K, Datta M, Jain JN, Chaubey K. (2016) DIVA technology: indispensable tool for the control of Johne’s disease. J Exp Biol. 4, 16-25.
  13. Diaz-San Segundo F, Medina GN, Stenfeldt C, Arzt J, de Los Santos T. (2017) Foot-and-mouth disease vaccines. Vet Microbiol. 206, 102-112.
  14. Dong XN, Chen YH. (2007) Marker vaccine strategies and candidat